investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

The Mitochondrial Genome and Ovarian Cancer Risk

Catherine Phelan

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Simon Gayther

University College London

London, United Kingdom

Paul Pharoah

University of Cambridge

Cambridge, United Kingdom

Catherine Phelan

Moffitt Cancer Center

Tampa, United States

University of South Florida

Tampa, United States

Related projects

Hans Schreiber

Manipulation of Tumor Specific Immunity

Ovary

Pathology

Alvaro Monteiro

Functional Analysis of Ovarian Cancer GWAS Loci

Ovary

Pathology

Ram Prasad

Nanoprobe-amplified spectroscopic assay for accurate assessment of ovarian cancer burden in peripheral blood

Ovary

Pathology

Selvendiran Karuppaiyah

Dissecting the Role of STAT3 and Targeting Ovarian Cancer

Ovary

Pathology

Sohrab Shah

The clonal dynamics of ovarian cancers: phylogenetic models of chemosensitivity and resistance

Ovary

Pathology

Bernard E Weissman

The Tumor Suppressor Role of SMARCA4 in SCCOHT

Ovary

Pathology

Theodore Brown

Impact of VEPH1 on cancer associated signaling pathways in the promotion of ovarian cancer

Ovary

Pathology

Kylie Walters

Ubiquitin Signaling

Ovary

Pathology

Meera Nanjundan

Transition from Endometriosis to Ovarian Cancer: Role of Iron-Induced Autophagy

Ovary

Pathology